Literature DB >> 26989974

Inadequacy of 3-month Oswestry Disability Index outcome for assessing individual longer-term patient experience after lumbar spine surgery.

Anthony L Asher1, Silky Chotai2, Clinton J Devin2, Theodore Speroff3, Frank E Harrell4, Hui Nian4, Robert S Dittus3,5, Praveen V Mummaneni6, John J Knightly7, Steven D Glassman8, Mohamad Bydon9, Kristin R Archer2,10, Kevin T Foley11, Matthew J McGirt1.   

Abstract

OBJECTIVE Prospective longitudinal outcomes registries are at the center of evidence-driven health care reform. Obtaining real-world outcomes data at 12 months can be costly and challenging. In the present study, the authors analyzed whether 3-month outcome measurements sufficiently represent 12-month outcomes for patients with degenerative lumbar disease undergoing surgery. METHODS Data from 3073 patients undergoing elective spine surgery for degenerative lumbar disease were entered into a prospective multicenter registry (N(2)QOD). Baseline, 3-month, and 12-month follow-up Oswestry Disability Index (ODI) scores were recorded. The absolute differences between actual 12- and 3-month ODI scores was evaluated. Additionally, the authors analyzed the absolute difference between actual 12-month ODI scores and a model-predicted 12-month ODI score (the model used patients' baseline characteristics and actual 3-month scores). The minimal clinically important difference (MCID) for ODI of 12.8 points and the substantial clinical benefit (SCB) for ODI of 18.8 points were used based on the previously published values. The concordance rate of achieving MCID and SCB for ODI at 3-and 12-months was computed. RESULTS The 3-month ODI scores differed from 12-month scores by an absolute difference of 11.9 ± 10.8, and predictive modeling estimations of 12-month ODI scores differed from actual 12-month scores by a mean (± SD) of 10.7 ± 9.0 points (p = 0.001). Sixty-four percent of patients (n = 1982) achieved an MCID for ODI at 3 months in comparison with 67% of patients (n = 2088) by 12 months; 51% (n = 1731) and 61% (n = 1860) of patients achieved SCB for ODI at 3 months and 12 months, respectively. Almost 20% of patients had ODI scores that varied at least 20 points (the point span of an ODI functional category) between actual 3- and 12-month values. In the aggregate analysis of achieving MCID, 77% of patients were concordant and 23% were discordant in achieving or not achieving MCID at 3 and 12 months. The discordance rates of achieving or not achieving MCID for ODI were in the range of 19% to 27% for all diagnoses and treatments (decompression with and without fusion). The positive and negative predictive value of 3-months ODI to predict 12-month ODI was 86% and 60% for MCID and 82% and 67% for SCB. CONCLUSIONS Based on their findings, the authors conclude the following: 1) Predictive methods for functional outcome based on early patient experience (i.e., baseline and/or 3-month data) should be used to help evaluate the effectiveness of procedures in patient populations, rather than serving as a proxy for long-term individual patient experience. 2) Prospective longitudinal registries need to span at least 12 months to determine the effectiveness of spine care at the individual patient and practitioner level.

Entities:  

Keywords:  MCID = minimal clinically important difference; N2QOD; N2QOD = National Neurosurgery Quality and Outcome Database; ODI; ODI = Oswestry Disability Index; Oswestry Disability Index; PRO patient-reported outcome; SCB = substantial clinical benefit; long-term; lumbar; patient-reported outcomes; registry; surgery

Mesh:

Year:  2016        PMID: 26989974     DOI: 10.3171/2015.11.SPINE15872

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  8 in total

1.  How does patient-rated outcome change over time following the surgical treatment of degenerative disorders of the thoracolumbar spine?

Authors:  Tamas F Fekete; M Loibl; D Jeszenszky; D Haschtmann; P Banczerowski; F S Kleinstück; H J Becker; F Porchet; A F Mannion
Journal:  Eur Spine J       Date:  2017-10-27       Impact factor: 3.134

2.  Endoscopic Transforaminal Lumbar Interbody Fusion With a Single Oblique PEEK Cage and Posterior Supplemental Fixation.

Authors:  Álvaro Dowling; Kai-Uwe Lewandrowski
Journal:  Int J Spine Surg       Date:  2020-10-29

3.  Determination of minimally clinically important differences for JOABPEQ measure after discectomy in patients with lumbar disc herniation.

Authors:  Parisa Azimi; Taravat Yazdanian; Edward C Benzel
Journal:  J Spine Surg       Date:  2018-03

4.  Minimal Clinically Important Difference in Patient-Reported Outcome Measures with the Transforaminal Endoscopic Decompression for Lateral Recess and Foraminal Stenosis.

Authors:  Kai-Uwe Lewandrowski; Paulo Sérgio Teixeira DE Carvalho; Paulo DE Carvalho; Anthony Yeung
Journal:  Int J Spine Surg       Date:  2020-04-30

5.  Trends in the use of patient-reported outcome instruments in neurosurgical adult thoracolumbar deformity and degenerative disease literature.

Authors:  Hanna Algattas; Jonathan Cohen; Nitin Agarwal; D Kojo Hamilton
Journal:  J Craniovertebr Junction Spine       Date:  2017 Apr-Jun

6.  Does the Number of Levels of Decompression Have an Impact on the Clinical Outcomes of Patients With Lumbar Degenerative Spondylolisthesis: A Retrospective Study in Single-Level Fused Patients.

Authors:  Glenn A Gonzalez; Daniel Franco; Guilherme Porto; Christopher Elia; Ellina Hattar; Kevin Hines; Aria Mahtabfar; Matthew O'Leary; Lucas Philipp; Elias Atallah; Thiago S Montenegro; Joshua Heller; Ashwini Sharan; Jack Jallo; James Harrop
Journal:  Cureus       Date:  2022-08-09

7.  Thoracolumbar Fusion in Extreme Obesity: Complications and Patient-Reported Outcomes.

Authors:  Jacob R Joseph; Jennifer Neva; Brandon W Smith; Mary O Strasser; Paul Park
Journal:  Int J Spine Surg       Date:  2019-02-22

8.  Does the severity of pain correlate with severity of functional disability? Factors influencing 'patient reported outcome measures' in spinal patients.

Authors:  Andrew P MacCormick; Himanshu Sharma
Journal:  SICOT J       Date:  2018-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.